Pharmazell (India) Private LtdFebruary 7, 2025

FDA 483 - Pharmazell (India) Private Ltd - February 07, 2025

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Pharmazell (India) Private Ltd

Record Details

During an inspection from February 3-7, 2025, the FDA observed significant deficiencies at Pharmazell (India) Private Ltd, an API manufacturer in Visakhapatnam. The primary concern was the firm's failure to conduct proper installation, operation, and performance qualification studies for multiple pieces of manufacturing equipment. This indicates a lapse in ensuring equipment is fit for its intended use in producing active pharmaceutical ingredients.

Company: Pharmazell (India) Private Ltd
Inspection Date: February 7, 2025
Product Type: Drugs
Office: Office of Inspections and Investigations
People: Olumide A. Akinyemi
Jessica S. Estriplet (Drug Investigator)

Open in Dashboard

ID · 251f3418-9bc4-45ff-b107-2c0ff8cf3692